My TransOvaLog In
Sep 19, 2025
Sioux Center, IA – September 18, 2025 – Trans Ova Genetics (Trans Ova), a leading provider of advanced bovine reproductive technologies, today announced it has acquired ReproLogix, a respected provider of embryo transfer and IVF services based in Fort Scott, KS. This strategic acquisition strengthens Trans Ova’s presence in a key market and enhances its ability to deliver world-class services to clients nationwide.
“ReproLogix has built an exceptional reputation for quality and client relationships,” said Kevin Hoogendoorn, CEO, Trans Ova Genetics. “By bringing their talented team and proven expertise into the Trans Ova family, we can offer our clients more capacity, expanded resources, and seamless service.”
Under the terms of the acquisition, ReproLogix’s team will join Trans Ova Genetics with minimal disruption. Clients will continue to receive the same services from the same people they know and trust, now supported by Trans Ova’s national network and advanced technologies. Nathan Wells, president of ReproLogix, will continue to operate ReproLogix as a Trans Ova Genetics satellite center in Fort Scott, KS, maintaining its in-clinic donor management services, donor housing, and pregnant recipient program to ensure continuity of care and a seamless experience for clients.
“We are excited to share that we have officially joined Trans Ova Genetics, a global leader in advanced reproductive technologies,” said Nathan Wells. “This partnership allows us to continue serving our clients with the same dedication and personalized support they have come to expect, while also strengthening our ability to deliver consistently high pregnancy rates with both frozen and fresh embryos.”
“By combining our expertise with the resources, innovation, and extensive network of Trans Ova Genetics, we can expand access to cutting-edge reproductive solutions, improve efficiency, and ultimately help our clients achieve greater success. Our team remains fully committed to your goals, ensuring a seamless experience with no interruption in service. Together with Trans Ova Genetics, we are confident this collaboration will bring even more value, reliability, and opportunity to cattle producers worldwide.”
The acquisition is effective September 18, 2025. In the coming weeks, ReproLogix and Trans Ova representatives will be reaching out to clients to answer questions and ensure a smooth transition.
Trans Ova Genetics is a leading provider of advanced reproductive solutions for the livestock industry, delivering cutting-edge technologies and personalized services designed to help producers multiply genetic progress across dairy, beef, small ruminant, and swine operations. With over four decades of experience, our “toolbox of services” includes invitro fertilization (IVF), embryo transfer, sexed semen programs, cloning, genetic preservation, and donor housing. Supported by a network of regional centers, satellite locations, and on-farm capabilities, we partner closely with producers to understand their breeding goals and deliver tailored solutions that enhance herd performance, sustainability, and profitability. Trans Ova operates under the URUS family of businesses, committed to empowering producers through innovation and excellence.
ReproLogix is a respected provider of advanced bovine reproductive technologies headquartered in Fort Scott, Kansas. The company offers embryo transfer, in-vitro fertilization (IVF), and related reproductive services designed to help producers accelerate
genetic progress and improve herd performance. Known for its skilled embryologists, personalized client support, and commitment to innovation, ReproLogix has built trusted relationships with cattle producers across the US. By combining hands-on expertise with cutting-edge laboratory capabilities, ReproLogix delivers high-quality, science-driven reproductive solutions that empower clients to achieve their breeding goals.
Media Contact:
Sara Kober
Director of Marketing, Trans Ova Genetics
Sara.Kober@transova.com | 800-999-3586
www.transova.com